|
|
|
PERSPECTIVE
1 Departments of Microbiology and Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, New York 10032, USA; 2 Department of Animal Biology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania 19104, USA
Ubiquitously expressed transcription factor Yin Yang 1 (YY1) has long been believed to play some role in immunoglobulin gene regulation, because it associates with multiple Ig enhancer elements including the heavy-chain intron and 3' enhancers as well as the Ig
3' enhancer (Park and Atchison 1991
; Gordon et al. 2003
). Early on, YY1 was noted to have bifunctional properties, in that it could either repress or activate transcription, depending on binding site context, protein interactions, or levels within the cell (Park and Atchison 1991
; Seto et al. 1991
; Shi et al. 1991
; Lee et al. 1994
1995
; Bushmeyer et al. 1995
). Numerous mechanisms of YY1 transcriptional control were observed and a number of activation/repression models were proposed (Galvin and Shi 1997
). YY1 function in transcription at the Ig loci was enigmatic, however, because no evidence exists for differential expression of YY1 during B-cell development, and deletion of enhancer YY1-binding sites had a marginal impact on enhancer activity as measured by transient expression assays (Park and Atchison 1991
). It was generally assumed that YY1 might control some aspect of chromatin structure at the Ig loci not completely recapitulated by transient expression assays.
Over the 16 years since its discovery, a very large number of genes regulated by YY1 were identified (Shrivastava and Calame 1994
; Thomas and Seto 1999
; Gordon et al. 2006
). In addition, YY1 was observed to interact with a large number of proteins including coactivators, corepressors, and other transcription factors (Thomas and Seto 1999
; Gordon et al. 2006
). More recently, YY1 was implicated in cell cycle control, oncogenesis, imprinting control, X-chromosome inactivation, and Polycomb Group (PcG) function (Sui et al. 2004
; Gordon et al. 2006
; Kim et al. 2006
, 2007
; Donohoe et al. 2007
). The huge numbers of processes believed to require YY1 function suggested that the protein would be crucial for development. Indeed, knockout of the gene results in peri-implantation lethality confirming its crucial function (Donohoe et al. 1999
), but the role in B-cell development could only be revealed by the conditional knockout (CKO) approach that is used by Shi and colleagues (Liu et al. 2007
) in this issue of Genes & Development.
Shi and colleagues (Liu et al. 2007
) created CKO mice lacking the gene for YY1 in B lymphocyte progenitors and observed a block in pro-B to pre-B-cell development. They found that pro-B cells lacking YY1 have normal DH-JH recombination but reduced frequency of VH-DHJH recombination, with the defect being most severe for more DH-distal VH genes. They further showed that pro-B cells lacking YY1 are defective in Ig heavy-chain (IgH) locus contraction, defined by close juxtaposition in nuclear chromatin of V and C gene segments separated from one another in the genome by large distances. Ig locus contraction has been observed previously by fluorescence in situ hybridization (FISH) in B cells undergoing V(D)J recombination (Kosak et al. 2002
) and has been suggested to be mechanistically important for recombination of distal V regions. Importantly, introduction of a rearranged heavy-chain gene only partially complemented the YY1 CKO phenotype, suggesting additional roles for YY1 in early B-cell development. YY1 thus becomes the second transcription factor shown to be required for IgH locus contraction and VH-DHJH rearrangement. Significantly, the results of Shi et al. (Liu et al. 2007
) show that YY1 does not affect expression of Pax5, the other transcription factor known to be required for locus contraction, VH-DHJH recombination, and B-cell commitment (Nutt et al. 1999
; Fuxa et al. 2004
). Furthermore, because faulty IgH locus contraction was the only defect related to VH-DHJH recombination observed by Shi et al. (Liu et al. 2007
) in the YY1 CKO pro-B cells, these data provide new support for the idea that locus contraction may, in fact, be required for VH-DHJH recombination. This is particularly important because the role of locus contraction in VH-DHJH recombination, as well as mechanisms regulating and mediating IgH locus contraction, remain poorly understood.
The data from Shi and colleagues (Liu et al. 2007
) also help to bring together some concepts that have been at "loose ends" for understanding regulation of VH-DHJH recombination. These include the roles of the core IgH intronic enhancer (iEµ), the transcription of unrearranged IgH gene segments, and the alteration of chromatin structure in the IgH locus for locus contraction. Below, we review current understanding of the requirements for VH-DHJH recombination in the context of the Shi paper (Liu et al. 2007
) and discuss how YY1 may act in this process.
| VH-DHJH recombination |
|---|
|
|
|---|
VH-DHJH recombination appears to occur sequentially on the two IgH alleles, allowing time to test the outcome of rearranging the first allele before the second allele is eligible for rearrangement. If rearrangement of the first allele encodes a functional µ heavy-chain protein, the transmembrane pre-B-cell receptor (pre-BCR), formed by association of µ with surrogate light chains (
5, Vpre-B), Ig
, and Ig
, signals the developing B cell to shut off VH-DHJH rearrangement of the second IgH allele. Only if rearrangement of the first allele is nonfunctional (i.e., out of translational reading frame) does the second allele rearrange. This sequence of events is necessary to achieve heavy-chain expression from a single allele (heavy-chain allelic exclusion) and the ultimate expression of antibody with a unique specificity on each B-cell clone. The mechanistic basis for sequential rearrangement is poorly understood. Based primarily on studies from the Ig
locus, it may involve asynchronous replication of the two alleles (Mostoslavsky et al. 2004
), monoallelic DNA looping (Sayegh et al. 2005
), monoallelic activation (Liang et al. 2004
), or monoallelic silencing (Liu et al. 2006
). pre-BCR signaling to inhibit second allele rearrangement correlates with repressive chromatin modifications (Johnson et al. 2003
; Chowdhury and Sen 2004
), loss of locus contraction, and repositioning of IgH chromosomes within the nucleus (Roldan et al. 2005
; Yang et al. 2005
). However, it has not yet been possible to distinguish causal from correlative events in this context.
Since the VH region covers >2.5 Mb, and the entire IgH locus is >3 Mb (Johnston et al. 2006
), locus contraction, which has been observed by FISH analyses to be developmentally correlated with VH-DHJH recombination (Kosak et al. 2002
), may be mechanistically important. More detailed analysis showed evidence for both locus contraction and DNA looping of the IgH locus in pro-B cells (Sayegh et al. 2005
), for locus contraction in the Ig
locus (Roldan et al. 2005
), and for decontraction of the IgH locus in pre-B cells when IgH rearrangements have ceased (Roldan et al. 2005
). It has been suggested that contraction and/or looping facilitates juxtaposition of VH gene segments with the DHJH segments for VH-DHJH recombination, and that decontraction may inhibit recombination to ensure allelic exclusion. Locus contraction or looping might be especially important for recombination of the more distal VH gene segments located >2 Mb 5' of the DH region, bringing them into proximity with rearranged DHJH gene segments so that VH-DHJH recombination can occur (Fig. 1; Roldan et al. 2005
; Sayegh et al. 2005
). A very recent report of reversible locus contraction in the TCR
and TCR
loci (Skok et al. 2007
) provides further support for the idea that locus contraction is important for V(D)J recombination. The mechanism or protein(s) that mediate locus contraction were heretofore unknown except for the requirement for Pax5 (Fuxa et al. 2004
) and Ezh2 (Su et al. 2003
), underscoring the importance of the finding that YY1 is also required for this event.
|
| Cis-acting elements in the IgH locus and the proteins that bind them |
|---|
|
|
|---|
The mechanism(s) by which iEµ enhances VH-DHJH recombination is not established and analysis of mice harboring the germline deletion (Perlot et al. 2005
) did not include an analysis of IgH chromosome condensation or looping. Many transcriptional regulators bind specifically to functional sites in iEµ (for review, see Calame and Sen 2004
). Significantly, YY1 binds at the µE1 site (Park and Atchison 1991
) and the Shi paper (Liu et al. 2007
) shows binding of YY1 in vivo to iEµ. Pax5, the only other DNA-binding protein known to be required for VH-DHJH recombination, is not known to bind iEµ, although multiple Pax5-binding sites reside within the VH genes themselves (discussed further below). Interestingly, although both YY1 and Pax5 bind in the 3'C
enhancer region located at the far 3' end of the IgH locus (Gordon et al. 2003
), a role for this enhancer in VH-DHJH recombination has not been demonstrated.
The action of iEµ and its associated proteins in VH-DHJH recombination could involve several mechanisms that are not mutually exclusive: (1) activation of transcription from VH promoters or promoters near the DJ region, thereby opening chromatin structure; (2) recruitment of enzymes, such as histone acetyltransferases, histone demethylases, or chromatin remodeling complexes that are needed to form open chromatin structure; and/or (3) recruitment and/or stabilization of juxtaposed DHJH and VH gene segments during VH-DHJH recombination.
In B cells with iEµ deleted, there is a 10- to 20-fold decrease in µ0 and Iµ transcripts, but no change in unrearranged VH transcripts (Perlot et al. 2005
). If iEµs primary mechanism in V(D)J recombination were to activate transcription of unrearranged genes, one would have expected its deletion to have a greater effect on DH-JH recombination than VH-DHJH recombination, because promoters in the vicinity of iEµ are activated by the enhancer, while unrearranged VH promoters are not. In fact, the opposite is the casedeletion had a greater effect on VH-DHJH recombination (Perlot et al. 2005
). It is also noteworthy that in the TCR
locus, an enhancer has been shown to enhance D
-J
recombination by causing both general chromatin opening and facilitation of a complex between D
1 and J
(Oestreich et al. 2006
).
The region of iEµ deleted by Perlot et al. (2005)
did not include the MARs, which flank iEµ on either side (Cockerill et al. 1987
). Interestingly MARs are also found near VH regions (Webb et al. 1991
; Goebel et al. 2002
), providing the possibility that they might help mediate juxtaposition of VH and DHJH gene segments to facilitate VH-DHJH rearrangement. Several proteins, including transcriptional activator Bright (Herrscher et al. 1995
) and the repressive cut-like protein Cux/CDP compete for binding in iEµ and VH MARs (Wang et al. 1999
; Goebel et al. 2002
). The atypical homeodomain protein SATB1, which packages active chromatin (Cai et al. 2006
), also binds MARs (Dickinson et al. 1997
). Interestingly, YY1 can bind to the nuclear matrix (Bushmeyer and Atchison 1998
; McNeil et al. 1998
), but the functional significance of this interaction is unclear. An earlier study addressed the role of the MARs in VH-DHJH recombination by studying embryonic stem cells having mutant IgH alleles with or without the MARs flanking iEµ (Sakai et al. 1999
). Using a RAG blastocyst complementation system, these authors showed a requirement for iEµ in VH-DHJH recombination, but no role for the flanking MARs. Subsequent work confirmed the importance of iEµ for VH-DHJH recombination using mice with germline deletion (Perlot et al. 2005
). Mice with germline deletion of both MARs and iEµ have not been reported. Interestingly, however, germline deletion of iEµ and the 5' MAR was reported to have a strong effect on DH-JH recombination, although effects on VH-DHJH recombination were not reported for this mutation (Afshar et al. 2006
). Thus, a role for iEµ MARs in VH-DHJH recombination is not yet clear.
There is evidence that sequences within the VH gene region are also important for VH-DHJH recombination. In contrast to iEµ, VH transcriptional promoters are relatively simple, depending primarily on octamer-binding proteins Oct-1 and Oct-2, and the coactivator OCA-B. Stat5 in association with octamer proteins is necessary for histone acetylation, transcription, and rearrangement of VH gene segments, but STAT5 does not affect IgH locus contraction (Bertolino et al. 2005
). However, a 1-Mb region in the far 5' end of the VH region associates with the nuclear lamina and may be important for subnuclear localization or condensation of IgH alleles (Yang et al. 2005
). In addition, many VH gene segments have Pax-5-binding sites in the coding regions (Zhang et al. 2006
). Pax-5 is required for VH-DHJH recombination of distal but not proximal VH gene segments (Hesslein et al. 2003
), although ectopic expression of Pax5 increases recombination of proximal, not distal VH genes (Fuxa et al. 2004
). Pax-5 is necessary for IgH locus contraction (Fuxa et al. 2004
) and has several known activities in the context of VH-DHJH recombination. Pax5 can recruit RAG proteins (Zhang et al. 2006
) to VH recombination signal sequences (RSSs). Although this would be expected to facilitate RAG-dependent cleavage, it is not clear whether/how RAG recruitment would affect locus contraction. Pax-5 expression also causes loss of H3K9 methylation, a repressive chromatin modification, at VH genes (Johnson et al. 2004
), and this might affect locus contraction. Pax5 binding to multiple sites in the VH region (Zhang et al. 2006
) might facilitate VH region juxtaposition/contraction, but the absence of known Pax5 sites in iEµ or the DJ region suggests a need for other proteins as well. Apparently, none of the Pax5 activities can substitute for YY1 in the context of VH-DHJH recombination, since Pax-5 levels are normal in the YY1 CKO pro-B cells that have defective VH-DHJH recombination.
| Transcription of unrearranged gene segments |
|---|
|
|
|---|
locus, transcription was shown to be required for V
-J
recombination (Abarrategui and Krangel 2006| Changes in chromatin structure of the IgH locus |
|---|
|
|
|---|
Locus contraction and DNA looping observed by FISH are developmentally correlated with VH-DHJH recombination (Kosak et al. 2002
; Sayegh et al. 2005
). However, this raises interesting questions about the chromatin structure of the "contracted" region. Contracted or heterochromatic chromatin in other settings has characteristic repressive features including absence of histone acetylation, the presence of H3K9 methylation, and presence of HP1. However, during VH-DHJH recombination, the IgH locus is apparently both contracted and at the same time has an open and accessible chromatin structure characterized by histone acetylation, loss of H3K9 methylation, nuclease sensitivity, germline transcription, and accessibility to RAG-dependent cleavage. YY1 interacts with numerous chromatin-modifying proteins including histone acetyltransferases, deacetylases, and methyltransferases (Thomas and Seto 1999
; Rezai-Zadeh et al. 2003
), and these interactions may contribute to IgH locus contraction and VH-DHJH rearrangement. Locus contraction may reflect looping back and tethering of the involved chromosomal segments rather than formation of compacted, inactive chromatin. In any case, the requirement for YY1 in locus contraction may provide entrée into characterizing the apparently unusual chromatin structure of the IgH locus during VH-DHJH rearrangement and may help us understand how the IgH region is simultaneously contracted and accessible to RAG-dependent recombination. It will also be important to determine whether YY1 is also required for recombination of the TCR
and TCR
loci, where locus contraction has been observed (Skok et al. 2007
).
| YY1 and VH-DHJH recombination |
|---|
|
|
|---|
A major unresolved question is whether the YY1 mutant phenotype affecting VH-DHJH recombination observed by Shi and colleagues (Liu et al. 2007
) is due to a direct effect caused by YY1 DNA-binding activity within the Ig loci, or whether the phenotype is an indirect effect caused by YY1 gene regulation activities. Shi and colleagues (Liu et al. 2007
) argue for a direct effect partly due to the observation that YY1 CKO does not affect expression of any of the proteins known to be involved in V(D)J rearrangement. According to the direct effect scenario, YY1 binds to the iEµ enhancer and perhaps to sites within the VH regions (although such VH-binding sites were not detected in initial chromatin immunoprecipitation [ChIP] studies). Pax5, along with YY1 or other proteins, binding to the IgH locus might stabilize rosette-like loops (see Fig. 1A), perhaps via self-association or interaction with additional proteins. Indeed, measurements of distances from the constant region gene segments to various VH gene segments using high-resolution FISH are most consistent with a rosette or flower structure for the VH region (C. Murre, pers. comm.). Further contraction of VH rosettes toward the constant region could be mediated by Pax5 and YY1 interacting with either a common structural component (such as the nuclear matrix) or by direct or indirect protein interactions (Fig. 1B). Possible direct effects by YY1 on Ig locus contraction are also implicated by its known associations with chromosomal structure mechanisms. YY1 can associate with the nuclear matrix (Bushmeyer and Atchison 1998
; McNeil et al. 1998
) and multiple YY1-binding sites lie within Imprinting Control Regions (Kim et al. 2006
, 2007
). In addition, YY1 serves as a cofactor with boundary factor Ctcf and is implicated in X-chromosome inactivation (Donohoe et al. 2007
). How all these functions relate to Ig locus contraction remain unclear, but the role of YY1 in these processes argues for YY1 involvement in global or large-scale regulatory mechanisms.
YY1 might also function in association with Pax5 in contraction and rearrangement. As mentioned above, the only other transcription factor with clear links to the Ig locus contraction mechanism is Pax5 (Fuxa et al. 2004
; Zhang et al. 2006
). Zhang et al. (2006)
showed that Pax5 can stimulate VH rearrangement as measured by in vitro assays and can even stimulate rearrangement of endogenous VH genes in 293T cells when cotransfected with Rag1, Rag2, and E47. The similarity of YY1 and Pax5 knockout phenotypes suggests that they function in the same contraction and rearrangement processes. Since YY1 and Pax5 cannot compensate for one another in these mechanisms, it could be argued that they function either together or in cooperation with one another. Zhang et al. (2006)
noted that many VH regions contain Pax5-binding sites, and these sites can bind to Pax5 in vivo as assayed by ChIP assay.
These VH gene sequences have been evaluated for potential YY1-binding sites, though they are degenerate, and therefore difficult to identify. However, nearly all YY1-binding sites contain the core sequence CCAT (ATGG in the reverse complement) (Hyde-DeRuyscher et al. 1995
). Remarkably, 73% of the 185 individual VH1, VH3, VH4, VHJ558, VH7183, and VHS107 genes contained one or more YY1 core sequences within 10 base pairs (bp) of a Pax5 site. While these sites are defined by only a 4-bp consensus, the close alignment of Pax5 and potential YY1 sites suggests that YY1 might cooperate with Pax5 either via DNA binding or by cooperating in protein interactions involved in the contraction or rearrangement processes. This possibility could be tested by assaying for cooperative Pax5YY1 DNA binding by electrophoretic mobility shift assay and for increased VDJ rearrangement by transfection experiments.
Whether or not YY1 and Pax5 cooperate in Ig locus contraction, a major unresolved question is the identity of the proteins that interact with YY1 and Pax5 to mediate the mechanism. The PcG connection to distal V gene rearrangement is intriguing. Mutation of the PcG protein Ezh2 results in reduction in distal VH gene rearrangement (Su et al. 2003
). PcG function has been proposed to be involved in Ig locus contraction, but the mechanism of targeting PcG proteins to the Ig locus is unknown. PcG proteins can assemble on DNA-binding elements called Polycomb Response Elements, but the individual PcG proteins do not bind to DNA with sequence specificity. Thus, the mechanism of their targeting to specific DNA sequences is unclear. Interestingly, YY1 is now known to function as a PcG protein and YY1 can recruit other PcG proteins to DNA, including Ezh2 (Atchison et al. 2003
; Caretti et al. 2004
; Srinivasan and Atchison 2004
; Srinivasan et al. 2005
; Wilkinson et al. 2006
). Is YY1 PcG function needed for the Ig locus contraction mechanism? Fortunately, a functional test for the role of YY1 PcG function in Ig contraction, distal VH rearrangement, and B-cell development is possible. A YY1 mutant (YY1
201226) exists that selectively ablates YY1 PcG function, but which retains other known YY1 functions (Wilkinson et al. 2006
). This mutant, expressed in YY1-null B cells, would enable one to determine the importance of YY1 PcG function for Ig locus contraction and for development past the pro-B-cell stage. If YY1 PcG function is needed for Ig locus contraction, YY1 might recruit PcG proteins to the Ig locus, which would then, in some presently unclear fashion, contribute to the locus contraction mechanism. YY1 might recruit PcG proteins either by binding adjacent to the Pax5 sites discussed above or by binding to the iEµ enhancer. Additional ChIP studies will be needed to explore these possibilities.
| Additional YY1 functions in B-cell development |
|---|
|
|
|---|
locus contraction is indeed affected by the YY1 CKO (Y. Shi pers. comm.). A second possible mechanism relates to the known effects of YY1 on cell proliferation. Knockout of YY1 can significantly impact cell growth, and thus, a stage-specific requirement for YY1 in controlling cell proliferation may exist (Sui et al. 2004
The known links of YY1 with epigenetic, global chromosomal structural, and cell-proliferation mechanisms provide possible connection points between numerous control pathways. The mutant YY1 phenotype detected by Shi and colleagues (Liu et al. 2007
) provides an important piece in the puzzle of early B-cell development and Ig locus contraction and rearrangement. Key proteins that are recruited to DNA by YY1 represent an important next step in deciphering the Ig locus contraction and VH-DHJH rearrangement processes.
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
E-MAIL klc1{at}columbia.edu; FAX (212) 305-1468. ![]()
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1559007
| References |
|---|
|
|
|---|
gene recombination by transcription. Nat. Immunol. 7: 11091115.[CrossRef][Medline]Affar, E.B., Gay, F., Shi, Y., Liu, H., Huarte, M., Wu, S., Collins, T., Li, E., and Shi, Y. 2006. Essential dosage-dependent functions of the transcription factor Yin Yang 1 in late embryonic development and cell cycle progression. Mol. Cell. Biol. 26: 35653581.
Afshar, R., Pierce, S., Bolland, D.J., Corcoran, A., and Oltz, E.M. 2006. Regulation of IgH gene assembly: Role of the intronic enhancer and 5'DQ52 region in targeting DHJH recombination. J. Immunol. 176: 24392447.
Alt, F.W., Yancopoulos, G.D., Blackwell, T.K., Wood, C., Thomas, E., Boss, M., Coffman, R., Rosenberg, N., Tonegawa, S., and Baltimore, D. 1984. Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J. 3: 12091219.[Medline]
Angelin-Duclos, C. and Calame, K. 1998. Evidence that immunoglobulin VH-DJ recombination does not require germ line transcription of the recombining variable gene segment. Mol. Cell. Biol. 18: 62536264.
Atchison, L., Ghias, A., Wilkinson, F., Bonini, N., and Atchison, M.L. 2003. The YY1 transcription factor functions as a PcG protein in vivo. EMBO J. 22: 13471358.[CrossRef][Medline]
Baumann, M., Mamais, A., McBlane, F., Xiao, H., and Boyes, J. 2003. Regulation of V(D)J recombination by nucleosome positioning at recombination signal sequences. EMBO J. 22: 51975207.[CrossRef][Medline]
Bertolino, E., Reddy, K., Medina, K.L., Pargana, E., Ihle, J., and Singh, H. 2005. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nat. Immunol. 6: 836843.[CrossRef][Medline]
Bolland, D.J., Wood, A.L., Johnston, C.M., Bunting, S.F., Morgan, G., Chakalova, L., Fraser, P.J., and Corcoran, A.E. 2004. Antisense intergenic transcription in V(D)J recombination. Nat. Immunol. 5: 630637.[CrossRef][Medline]
Bushmeyer, S.M. and Atchison, M.L. 1998. Identification of YY1 sequences necessary for association with the nuclear matrix and for transcriptional repression functions. J. Cell. Biochem. 68: 484499.[CrossRef][Medline]
Bushmeyer, S., Park, K., and Atchison, M.L. 1995. Characterization of functional domains within the multifunctional transcription factor, YY1. J. Biol. Chem. 270: 3021330220.
Cai, S., Lee, C.C., and Kohwi-Shigematsu, T. 2006. SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat. Genet. 38: 12781288.[CrossRef][Medline]
Calame, K. and Sen, R. 2004. Transcription of immunoglobulin genes. In Molecular biology of B cells (eds. F.W. Alt, T. Honjo, and M. Neuberger), pp. 83100. Elsevier, Amsterdam, The Netherlands.
Caretti, G., Di Padova, M., Micales, B., Lyons, G.E., and Sartorelli, V. 2004. The polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes & Dev. 18: 26272638.
Chowdhury, D. and Sen, R. 2004. Mechanisms for feedback inhibition of the immunoglobulin heavy chain locus. Curr. Opin. Immunol. 16: 235240.[CrossRef][Medline]
Cobb, R.M., Oestreich, K.J., Osipovich, O.A., and Oltz, E.M. 2006. Accessibility control of V(D)J recombination. Adv. Immunol. 91: 45109.[CrossRef][Medline]
Cockerill, P.N., Yuen, M.H., and Garrard, W.T. 1987. The enhancer of the immunoglobulin heavy chain locus is flanked by presumptive chromosomal loop anchorage elements. J. Biol. Chem. 262: 53945397.
Dickinson, L.A., Dickinson, C.D., and Kohwi-Shigematsu, T. 1997. An atypical homeodomain in SATB1 promotes specific recognition of the key structural element in a matrix attachment region. J. Biol. Chem. 272: 1146311470.
Donohoe, M.E., Zhang, X., McGinnis, L., Biggers, J., Li, E., and Shi, Y. 1999. Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol. Cell. Biol. 19: 72377244.
Donohoe, M.E., Zhang, L.-F., Xu, N., Shi, Y., and Lee, J.T. 2007. Identification of a Ctcf cofactor, YY1, for the X chromosome binary switch. Mol. Cell 25: 4356.[CrossRef][Medline]
Fuxa, M.J.S., Souabni, A., Salvagiotto, G., Roldan, E., and Busslinger, M. 2004. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes & Dev. 18: 411422.
Galvin, K.M. and Shi, Y. 1997. Multiple mechanisms of transcriptional repression by YY1. Mol. Cell. Biol. 17: 37233732.[Abstract]
Goebel, P., Montalbano, A., Ayers, N., Kompfner, E., Dickinson, L., Webb, C.F., and Feeney, A.J. 2002. High frequency of matrix attachment regions and cut-like protein x/CCAAT-displacement protein and B cell regulator of IgH transcription binding sites flanking Ig V region genes. J. Immunol. 169: 24772487.
Gordon, S.J., Saleque, S., and Birshtein, B.K. 2003. Yin Yang 1 is a lipopolysaccharide-inducible activator of the murine 3' Igh enhancer, hs3. J. Immunol. 170: 55495557.
Gordon, S., Akopyan, G., Garban, H., and Bonavida, B. 2006. Transcription factor YY1: Structure, function, and therapeutic implications in cancer biology. Oncogene 25: 11251142.[CrossRef][Medline]
Herrscher, R.F., Kaplan, M.H., Lelsz, D.L., Das, C., Scheuermann, R., and Tucker, P.W. 1995. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: A B cell-specific trans-activator that describes a new DNA-binding protein family. Genes & Dev. 9: 30673082.
Hesslein, D.G., Pflugh, D.L., Chowdhury, D., Bothwell, A.L., Sen, R., and Schatz, D.G. 2003. Pax5 is required for recombination of transcribed, acetylated, 5' IgH V gene segments. Genes & Dev. 17: 3742.
Hyde-DeRuyscher, R.P., Jennings, E., and Shenk, T. 1995. DNA binding sites for the transcriptional activator/repressor YY1. Nucleic Acids Res. 23: 44574465.
Iwama, A., Oguro, H., Negishi, M., Kato, Y., Morita, Y., Tsukui, H., Ema, H., Kamijo, T., Katoh-Fukui, Y., Koseki, H., et al. 2004. Enhanced self-renewal of hematopoietic stem cells mediated by the Polycomb gene product Bmi-1. Immunity 21: 843851.[CrossRef][Medline]
Jackson, A.M. and Krangel, M.S. 2006. Turning T-cell receptor
recombination on and off: More questions than answers. Immunol. Rev. 209: 129141.[CrossRef][Medline]
Jacobs, J.J.L., Kieboom, K., Marino, S., DePinho, R.A., and van Lohuizen, M. 1999. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164168.[CrossRef][Medline]
Johnson, K., Angelin-Duclos, C., Park, S., and Calame, K.L. 2003. Changes in histone acetylation are associated with differences in accessibility of V(H) gene segments to V-DJ recombination during B-cell ontogeny and development. Mol. Cell. Biol. 23: 24382450.
Johnson, K., Pflugh, D.L., Yu, D., Hesslein, D.G., Lin, K.I., Bothwell, A.L., Thomas-Tikhonenko, A., Schatz, D.G., and Calame, K. 2004. B cell-specific loss of histone 3 lysine 9 methylation in the V(H) locus depends on Pax5. Nat. Immunol. 5: 853861.[CrossRef][Medline]
Johnston, C.M., Wood, A.L., Bolland, D.J., and Corcoran, A.E. 2006. Complete sequence assembly and characterization of the C57BL/6 mouse Ig heavy chain V region. J. Immunol. 176: 42214234.
Jung, D., Giallourakis, C., Mostoslavsky, R., and Alt, F.W. 2006. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu. Rev. Immunol. 24: 541570.[CrossRef][Medline]
Kim, J.D., Hinz, A.K., Bergmann, A., Huang, J.M., Ovcharenko, I., Stubbs, L., and Kim, J. 2006. Identification of clustered YY1 binding sites in imprinting control regions. Genome Res. 16: 901911.
Kim, J.D., Hinz, A.K., Choo, J.H., Stubbs, L., and Kim, J. 2007. YY1 as a controlling factor for the Peg3 and Gnas imprinted domains. Genomics 89: 262269.[CrossRef][Medline]
Kosak, S.T., Skok, J.A., Medina, K.L., Riblet, R., Le Beau, M.M., Fisher, A.G., and Singh, H. 2002. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296: 158162.
Kurosawa, Y., von Boehmer, H., Haas, W., Sakano, H., Trauneker, A., and Tonegawa, S. 1981. Identification of D segments of immunoglobulin heavy-chain genes and their rearrangement in T lymphocytes. Nature 290: 565570.[CrossRef][Medline]
Kwon, J., Imbalzano, A.N., Matthews, A., and Oettinger, M.A. 1998. Accessibility of nucleosomal DNA to V(D)J cleavage is modulated by RSS positioning and HMG1. Mol. Cell 2: 829839.[CrossRef][Medline]
Lee, T.-C., Zhang, Y., and Schwartz, R.J. 1994. Bifunctional transcriptional properties of YY1 in regulating muscle actin and c-myc gene expression during myogenesis. Oncogene 9: 10471052.[Medline]
Lee, J.-S., Galvin, K.M., See, R.H., Eckner, R., Livingston, D., Moran, E., and Shi, Y. 1995. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by EIA-associated protein p300. Genes & Dev. 9: 11881198.
Liang, H.E., Hsu, L.Y., Cado, D., and Schlissel, M.S. 2004. Variegated transcriptional activation of the immunoglobulin
locus in pre-b cells contributes to the allelic exclusion of light-chain expression. Cell 118: 1929.[CrossRef][Medline]
Liu, Z., Widlak, P., Zou, Y., Xiao, F., Oh, M., Li, S., Chang, M.Y., Shay, J.W., and Garrard, W.T. 2006. A recombination silencer that specifies heterochromatin positioning and Ikaros association in the immunoglobulin
locus. Immunity 24: 405415.[CrossRef][Medline]
Liu, H., Schmidt-Supprian, M., Shi, Y., Hobeika, E., Barteneva, N., Jumaa, H., Pelanda, R., Reth, M., Skok, J., Rajewsky, K., et al. 2007. Yin Yang 1 is a critical regulator of B-cell development. Genes & Dev. (this issue), 10.1101/gad.1529307.
McNeil, S., Guo, B., Stein, J., Lian, J.B., Bushmeyer, S., Seto, E., Atchison, M.L., Penman, S., van Wijnen, A.J., and Stein, G.S. 1998. Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: The C-terminus is a principal determinant for nuclear trafficking. J. Cell. Biochem. 68: 500510.[CrossRef][Medline]
Mostoslavsky, R., Alt, F.W., and Rajewsky, K. 2004. The lingering enigma of the allelic exclusion mechanism. Cell 118: 539544.[CrossRef][Medline]
Nutt, S.L., Heavey, B., Rolink, A.G., and Busslinger, M. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401: 556562.[CrossRef][Medline]
Oestreich, K.J., Cobb, R.M., Pierce, S., Chen, J., Ferrier, P., and Oltz, E.M. 2006. Regulation of TCR
gene assembly by a promoter/enhancer holocomplex. Immunity 24: 381391.[CrossRef][Medline]
Oltz, E.M., Alt, F.W., Lin, W.C., Chen, J., Taccioli, G., Desiderio, S., and Rathbun, G. 1993. A V(D)J recombinase-inducible B-cell line: Role of transcriptional enhancer elements in directing V(D)J recombination. Mol. Cell. Biol. 13: 62236230.
Park, K. and Atchison, M.L. 1991. Isolation of a candidate repressor/activator, NF-E1 (YY-1,
), that binds to the immunoglobulin
3' enhancer and the immunoglobulin heavy-chain µE1 site. Proc. Natl. Acad. Sci. 88: 98049808.
Perlot, T., Alt, F.W., Bassing, C.H., Suh, H., and Pinaud, E. 2005. Elucidation of IgH intronic enhancer functions via germ-line deletion. Proc. Natl. Acad. Sci. 102: 1436214367.
Rezai-Zadeh, N., Zhang, X., Namour, F., Fejer, G., Wen, Y.D., Yao, Y.L., Gyory, I., Wright, K., and Seto, E. 2003. Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Genes & Dev. 17: 10191029.
Roldan, E., Fuxa, M., Chong, W., Martinez, D., Novatchkova, M., Busslinger, M., and Skok, J.A. 2005. Locus decontraction and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene. Nat. Immunol. 6: 3141.[CrossRef][Medline]
Sakai, E., Bottaro, A., Davidson, L., Sleckman, B.P., and Alt, F.W. 1999. Recombination and transcription of the endogenous Ig heavy chain locus is effected by the Ig heavy chain intronic enhancer core region in the absence of the matrix attachment regions. Proc. Natl. Acad. Sci. 96: 15261531.
Sayegh, C., Jhunjhunwala, S., Riblet, R., and Murre, C. 2005. Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells. Genes & Dev. 19: 322327.
Seto, E., Shi, Y., and Shenk, T. 1991. YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature 354: 241245.[CrossRef][Medline]
Shi, Y., Seto, E., Chang, L.-S., and Shenk, T. 1991. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67: 377388.[CrossRef][Medline]
Shrivastava, A. and Calame, K. 1994. An analysis of genes regulated by the multi-functional transcriptional regulatory Yin Yang-1. Nucleic Acids Res. 22: 51515155.
Skok, J., Gisler, R., Novatchkova, M., Farmer, D., de Laat, W., and Busslinger, M. 2007. Reversible contraction by looping of the Tcra and Tcrb loci in rearranging thymocytes. Nat. Immunol. 8: 378387.[CrossRef][Medline]
Srinivasan, L. and Atchison, M.L. 2004. YY1 DNA binding and PcG recruitment Requires CtBP. Genes & Dev. 18: 25962601.
Srinivasan, L., Pan, X., and Atchison, M.L. 2005. Transient requirements of YY1 expression for PcG transcriptional rescue and phenotypic rescue. J. Cell. Biochem. 96: 689699.[CrossRef][Medline]
Su, I.-h., Basavaraj, A., Krutchinsky, A.N., Hobert, O., Ullrich, A., Chait, B.T., and Tarakhovsky, A. 2003. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 4: 124131.[CrossRef][Medline]
Sui, G., Affar, E.B., Shi, Y., Brignone, C., Wall, N.R., Yin, P., Donohue, M., Luke, M.P., Calvo, D., Grossman, S.R., et al. 2004. Yin Yang 1 is a negative regulator of p53. Cell 117: 859872.[CrossRef][Medline]
Thomas, M.J. and Seto, E. 1999. Unlocking the mechanisms of transcription factor YY1: Are chromatin modifying enzymes the key? Gene 236: 197208.[CrossRef][Medline]
Wang, Z., Goldstein, A., Zong, R.T., Lin, D., Neufeld, E.J., Scheuermann, R.H., and Tucker, P.W. 1999. Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator. Mol. Cell. Biol. 19: 284295.
Webb, C.F., Das, C., Eneff, K.L., and Tucker, P.W. 1991. Identification of a matrix-associated region 5' of an immunoglobulin heavy chain variable region gene. Mol. Cell. Biol. 11: 52065211.
Wilkinson, F.H., Park, K., and Atchison, M.L. 2006. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc. Natl. Acad. Sci. 103: 1929619301.
Yancopoulos, G.D. and Alt, F.W. 1985. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40: 271281.[CrossRef][Medline]
Yang, Q., Riblet, R., and Schildkraut, C.L. 2005. Sites that direct nuclear compartmentalization are near the 5' end of the mouse immunoglobulin heavy-chain locus. Mol. Cell. Biol. 25: 60216030.
Zhang, Z., Espinoza, C.R., Yu, Z., Stephan, R., He, T., Williams, G.S., Burrows, P.D., Hagman, J., Feeney, A.J., and Cooper, M.D. 2006. Transcription factor Pax5 (BSAP) transactivates the RAG-mediated V(H)-to-DJ(H) rearrangement of immunoglobulin genes. Nat. Immunol. 7: 616624.[CrossRef][Medline]
Related Article
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Genes & Dev. 2007 21: 1179-1189.
This article has been cited by other articles:
![]() |
C.-R. Xu, L. Schaffer, S. R. Head, and A. J. Feeney Reciprocal patterns of methylation of H3K36 and H3K27 on proximal vs. distal IgVH genes are modulated by IL-7 and Pax5 PNAS, June 24, 2008; 105(25): 8685 - 8690. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jacob, R. Hod-Dvorai, S. Schif-Zuck, and O. Avni Unconventional Association of the Polycomb Group Proteins with Cytokine Genes in Differentiated T Helper Cells J. Biol. Chem., May 9, 2008; 283(19): 13471 - 13481. [Abstract] [Full Text] [PDF] |
||||